0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Research Letters |

Interdigitating Dendritic Cell Sarcoma of the Eyelid With a Rapidly Fatal Course FREE

Ingrid Boldin, MD; Gudrun Brix-Grünwald, MD; Michael M. Scarpatetti, MD; Christine Beham-Schmid, MD, PhD; Angelika Klein, MD
Arch Ophthalmol. 2008;126(5):738-740. doi:10.1001/archopht.126.5.738.
Text Size: A A A
Published online

Interdigitating dendritic cells participate in the immune system as antigen-presenting cells, stimulating T lymphocytes. Interdigitating dendritic cells normally are localized in the T-cell–rich areas of lymph nodes and are believed to be derived from hematopoietic precursors and to belong to the mononuclear phagocytic system. Interdigitating dendritic cells sarcoma is an extremely rare malignancy derived from these antigen-presenting cells normally localized in lymphoid organs. Only 45 cases have been reported in the literature to date.1,2 We are unaware of previous reports of this sarcoma in the eyelid and could not find any reference to it in a MEDLINE search.

A 72-year-old man who had an unknown recurrent lesion in his lower right eyelid for 8 months was referred to our department. Two prior biopsies revealed a nevoid lesion and dermatofibroma. The patient was referred to our clinic when the tumor recurred. His best-corrected visual acuity was 0.8 OD. A 20-mm × 6-mm multinodular, ulcerated tumor was present on his right lower eyelid (Figure 1). The anterior chamber and the vitreous were free of inflammation and the lens revealed a mild senile cataract. Thepatient underwent sufficient surgical resection with a 4-mm–wide tumor-free margin and reconstruction using a tarsoconjunctival flap combined with a skin graft. Microscopically, the tumor consisted of medium to large spindle-shaped cells with hyperchromatic nuclei. The cells were arranged in fascicles and formed whorls. The mitotic count was high (Figure 2). The final diagnosis was interdigitating dendritic cell sarcoma. The tumor cells strongly expressed S-100 protein, and many tumor cells showed reactivity with antibodies to lysozyme and CD68 as well as CD45 (Figure 3). Numerous small, reactive CD3-positive T lymphocytes were mixed. Some tumor cells were positive for CD83 and fascin. No reactivity was seen with antibodies to cytokeratins, HMB-45, Melan-A, or CD1a or as markers for follicular dendritic cells, such as CD21, CD23, and CD35. The tumor staging revealed no metastatic disease. After careful deliberation of treatment options with his oncologist, the patient declined chemotherapy and local radiation therapy. Two years later, the patient had a local recurrence and metastatic lung and liver disease. A biopsy of a presumed metastasis in the lung confirmed the diagnosis. His clinical condition deteriorated and he died rapidly.

Place holder to copy figure label and caption
Figure 1.

Photograph showing a multinodular tumor with ulcerations of the lower eyelid.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.

Microscopic investigation revealed a tumor with a whorled and fascicular growth pattern of medium to large spindle-shaped cells with hyperchromatic nuclei and numerous mitoses (hematoxylin-eosin; original magnification ×200; inset magnification ×400).

Graphic Jump Location
Place holder to copy figure label and caption
Figure 3.

Immunohistochemical investigation showed that the tumor cells strongly expressed S-100 protein (left side) and many tumor cells were positive for CD68 (right side) (stained using the streptavidin–biotin complex method; original magnification ×400).

Graphic Jump Location

Interdigitating dendritic cell sarcoma is anextremely rare malignancy derived from antigen-presenting cells. Monocytes and related cells can be divided into 2 major categories: phagocytes and dendritic cells. The dendritic cells include (1) the follicular dendritic cell, (2) the Langerhans cell, (3) the intestinal dendritic cell, (4) the indeterminate cell, and (5) the interdigitating dendritic cell. Special immunohistochemical markers help to classify these dendritic cell neoplasms. The immunohistochemical diagnosis in this case was based on the World Health Organization classification for hematopoietic and lymphoid tissues.3 Patients with interdigitating dendritic cell sarcoma usually have lymph-node enlargement at initial examination, though they rarely have extranodal disease. A solitary skin tumor similar to our patient's was reported by Miracco et al.4 This sarcoma has a high potential of local recurrence and systemic disease. Of only 45 cases that have been reported in the world literature, the median overall survival (Kaplan-Meier method) from the time of diagnosis is reported to be 15 months.5 There is no consensus on a standard chemotherapy or radiation therapy regimen for interdigitating dendritic cell sarcoma. Chemotherapy regimens used in malignant lymphoma showed variable degrees of remission; field radiation seems to be the best treatment of localized disease.6

To our knowledge, interdigitating dendritic cell sarcoma has not involved the eyelid. Although optimal therapy for this tumor is yet to be determined, adjuvant chemotherapy or radiation therapy may be reasonable given its highly malignant course.

Correspondence: Dr Boldin, Department of Ophthalmology, Medical University Graz, Auenbruggerplatz 4, A-8036 Graz, Austria (ingrid.boldin@yahoo.de).

Financial Disclosure: None reported.

Kanaan  HAl-Maghrabi  JLinjawi  AAl-Abbassi  ADandan  AHaider  AR Interdigitating dendritic cell sarcoma of the duodenum with rapidly fatal course: a case report and review of the literature. Arch Pathol Lab Med 2006;130 (2) 205- 208
PubMed
Jayaram  GMun  KSElsayed  EMSangkar  JV Interdigitating dendritic reticulum cell sarcoma: cytologic, histologic and immunocytochemical features. Diagn Cytopathol 2005;33 (1) 43- 48
PubMed Link to Article
Jaffe  ESHarris  NLStein  HVardiman  JW Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues. Lyon  France IARC Press2001;284- 285World Health Organization Classification of Tumours 3
Miracco  CRaffaelli  Mde Santi  MMFimiani  MTosi  P Solitary cutaneous reticulum cell tumor: enzyme-immunohistochemical and electron-microscopic analogies with IDRC sarcoma. Am J Dermatopathol 1988;10 (1) 47- 53
PubMed Link to Article
Fonseca  RYamakawa  MNakamura  S  et al.  Follicular dendritic cell sarcoma and interdigitating reticulum cell sarcoma: a review. Am J Hematol 1998;59 (2) 161- 167
PubMed Link to Article
Gaertner  EMTsokos  MDerringer  GANeuhauser  TSArciero  CAndriko  JA Interdigitating dendritic cell sarcoma: a report of four cases and review of the literature. Am J Clin Pathol 2001;115 (4) 589- 597
PubMed Link to Article

Figures

Place holder to copy figure label and caption
Figure 1.

Photograph showing a multinodular tumor with ulcerations of the lower eyelid.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.

Microscopic investigation revealed a tumor with a whorled and fascicular growth pattern of medium to large spindle-shaped cells with hyperchromatic nuclei and numerous mitoses (hematoxylin-eosin; original magnification ×200; inset magnification ×400).

Graphic Jump Location
Place holder to copy figure label and caption
Figure 3.

Immunohistochemical investigation showed that the tumor cells strongly expressed S-100 protein (left side) and many tumor cells were positive for CD68 (right side) (stained using the streptavidin–biotin complex method; original magnification ×400).

Graphic Jump Location

Tables

References

Kanaan  HAl-Maghrabi  JLinjawi  AAl-Abbassi  ADandan  AHaider  AR Interdigitating dendritic cell sarcoma of the duodenum with rapidly fatal course: a case report and review of the literature. Arch Pathol Lab Med 2006;130 (2) 205- 208
PubMed
Jayaram  GMun  KSElsayed  EMSangkar  JV Interdigitating dendritic reticulum cell sarcoma: cytologic, histologic and immunocytochemical features. Diagn Cytopathol 2005;33 (1) 43- 48
PubMed Link to Article
Jaffe  ESHarris  NLStein  HVardiman  JW Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues. Lyon  France IARC Press2001;284- 285World Health Organization Classification of Tumours 3
Miracco  CRaffaelli  Mde Santi  MMFimiani  MTosi  P Solitary cutaneous reticulum cell tumor: enzyme-immunohistochemical and electron-microscopic analogies with IDRC sarcoma. Am J Dermatopathol 1988;10 (1) 47- 53
PubMed Link to Article
Fonseca  RYamakawa  MNakamura  S  et al.  Follicular dendritic cell sarcoma and interdigitating reticulum cell sarcoma: a review. Am J Hematol 1998;59 (2) 161- 167
PubMed Link to Article
Gaertner  EMTsokos  MDerringer  GANeuhauser  TSArciero  CAndriko  JA Interdigitating dendritic cell sarcoma: a report of four cases and review of the literature. Am J Clin Pathol 2001;115 (4) 589- 597
PubMed Link to Article

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 9

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections